The recent FDA guidance on diversity in clinical trials, released in June 2024, marks a pivotal step toward more inclusive clinical research.

Meet Amanda Soto, a seasoned Certified Mobile Research Nurse (CMRN) at PCM Trials. CMRNs play a vital role in supporting participant optionality in clinical trials by traveling to participants anytime, anywhere to conduct mobile visits.

In August 2024, experts in clinical trial research including Dr. Rohit Aggarwal, Principal Investigator of the decentralized Myositis Interstitial Lung Disease Nintedanib Trial (MINT) at the University of Pittsburgh, came together on a virtual panel to discuss the applications and benefits of deploying mobile nurse visits in an interstitial lung disease study.

Jonathan Ernst, Vice President of In-Home Solutions at PCM Trials, shared his insights on the evolving landscape of decentralized clinical trials (DCTs) in a recent interview.

PCM Trials and EmVenio Research, a PCM Trials Company are pleased to announce the addition of Jeff Huntsman to the leadership team as Chief Commercial Officer. Jeff brings over 30 years of experience in commercial planning, global business development, and scaling organizations in the healthcare and life sciences industry.

Meet Hope Horton, a dedicated Certified Mobile Research Nurse (CMRN) at PCM Trials.

PCM Trials is excited to announce that we have successfully self-certified for the EU-U.S. Data Privacy Framework (DPF), the UK Extension to the EU-U.S. DPF, and the Swiss-U.S. DPF.

EmVenio Research announces an exclusive partnership with Prime Healthcare and Health Wizz.

Advancements in Decentralized Clinical Trials: The Impact of AI on Mobile Visits View our on-demand webinar now! In March 2024, the US FDA issued its guidance, “Artificial Intelligence & Medical

Quality in Motion: Meet Our Mobile Clinicians: Nikki Degreeff Meet Nikki Degreeff, a Clinical Project Manager who began her journey with PCM Trials as a Certified Mobile Research Nurse (CMRN).